Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bromelain + papain + rutoside + trypsin
- Development stage
- Preclinical
- Lead developer
- Intra Life
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
Intramoto-XP is an oral fixed-dose combination tablet developed by Intra Life. It contains a synergistic blend of proteolytic enzymes—trypsin (96 mg), bromelain (180 mg), and papain (120 mg)—along with the antioxidant flavonoid rutoside trihydrate (200 mg). This combination is indicated for the treatment of inflammation, pain, swelling, and edema associated with musculoskeletal injuries, soft-tissue trauma, and post-operative or post-traumatic conditions. The proteolytic enzymes work by breaking down inflammatory proteins and debris at the site of injury, which improves blood flow and facilitates tissue repair. Rutoside acts as an antioxidant to strengthen blood vessels, reduce capillary permeability, and neutralize free radicals, thereby preventing further swelling and supporting the body's natural healing processes.
- Brand names
- Intramoto-XPIntramoto-XP TABS
- Other names
- Bromelain, Papain, Rutoside and TrypsinTrypsin + Bromelain + Rutoside + PapainTrypsin, Bromelain, Rutoside and PapainTrypsin, Bromelain, Rutoside, Papain
02
Targets
AKR1C3 (Aldo-keto reductase family 1 member C3)CBR1 (Carbonyl reductase 1)KNG1 (High-molecular-weight kininogen)MUC1 (Mucin-1 Antigen)MUC16 (Mucin-16)MUC4 (Mucin-4)MUC5AC (Mucin-5AC)MUC5B (Mucin-5B)TLR4 (Toll-like receptor 4)PAR2 (Protease-activated receptor 2)
Beyond the preview
Go deeper on bromelain + papain + rutoside + trypsin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bromelain + papain + rutoside + trypsin.